Product information

Current status:

Cancelled Pre Market

Current status date:

2017-08-30

Original market date: ^{See footnote 1}

Product name:

BCI SALBUTAMOL INHALATION SOLUTION

DIN:

02259591 Electronic product monograph is not available

Company:

BAKER CUMMINS INC
3900 1 Place Ville-Marie
Montréal
Quebec
Canada H3B 4M7

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Inhalation

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

12:12.08.12 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

R03AC02 SALBUTAMOL

Active ingredient group (AIG) number:^{See footnote5}

0108887001